Early detection and public health interventions are critical in improving sepsis survival rates and limiting its long-term ...

The US company’s rabies candidate, RBI-4000, was able to elicit an immune response comparable to Bavarian Nordic’s RavAvert.

The partnership between the US military and the body and the non-profit will examine three drugs as potential therapies ...

MSD has commenced the Phase III trial to assess zilovertamab vedotin combined with R-CHP to treat individuals with previously ...

A total of 113 subjects were enrolled in the trial. Credit: SofikoS / Shutterstock. Palatin Technologies has completed its Phase II study, BMT-801, evaluating the joint administration of melanocortin ...

Lupus nephritis is an inflammation of the kidneys caused by systemic lupus erythematosus (SLE). Credit: MirageC via Getty Images. Roche’s subsidiary Genentech has shared positive Phase III data with ...

Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...

Annovis Bio has commenced the treatment of subjects in a Phase III clinical trial of buntanetap in treating early Alzheimer's ...

A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...

Qlaris Bio has reported positive topline outcomes from two Phase II US trials of QLS 111 in individuals with POAG and OHT.

Breast cancer is the most common cancer among women in the UK, with one in seven women being diagnosed with breast cancer in ...

The first-in-human SCS trial saw all three SMA patients able to increase their walking distance within six minutes to 20 meters.